Evidence map›Paper›PMID 30847197›Full record

ArticleClinical case reports2019

Acute promyelocytic leukemia presenting as recurrent spinal myeloid sarcomas 3 years before developing leukemia: A case report with review of literature.

Tomoko Yamashita, Akihiko Nishijima, Yuma Noguchi, Kensuke Narukawa, Gaku Oshikawa, Hina Takano

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. An unusual myeloid sarcoma.Proceedings (Baylor University. Medical Center) · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Myeloid sarcoma of the tongue as a first manifestation of acute promyelocytic leukemia: A case report.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tomoko YamashitaDepartment of Internal Medicine Toshiba General Hospital Tokyo Japan.
Akihiko NishijimaDepartment of Hematology Japan Red Cross Musashino Hospital Tokyo Japan.
Yuma NoguchiDepartment of Hematology Japan Red Cross Musashino Hospital Tokyo Japan.
Kensuke NarukawaDepartment of Hematology Japan Red Cross Musashino Hospital Tokyo Japan.
Gaku OshikawaDepartment of Hematology Japan Red Cross Musashino Hospital Tokyo Japan.
Hina TakanoDivision of Blood Transfusion Japan Red Cross Musashino Hospital Tokyo Japan.ORCID https://orcid.org/0000-0002-8919-7254
Musashino Red Cross Hospital · JPTokyo Shinagawa Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The de novo myeloid sarcoma (MS) type of acute promyelocytic leukemia (APL) is rare, and clinical features may differ from extramedullary diseases in advanced APL. Many cases occur as a spinal tumor, and some occur in the absence of bone-marrow diseases or coagulation abnormalities. Fluorescence in situ hybridization analysis of MS tissue is useful for accurate diagnosis, even in preserved tissue.

Indexed as

acute promyelocytic leukemiafluorescence in situ hybridizationmyeloid sarcomaspinal tumor

Identifiers

PMID30847197
PMCPMC6389481
OpenAlexW2909786256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.